Kura Oncology increases inducement option plan share reserve by 1.9M shares to total 2.5M

Kura Oncology, Inc.

Board approved amendment to 2023 Inducement Option Plan, adding 1,900,000 shares for a new total of 2,500,000 shares reserved.
Awards limited to nonstatutory stock options for new hires as an inducement material to employment.
Plan approved without stockholder approval under Nasdaq Listing Rule 5635(c)(4).
Eligible recipients are individuals not previously employees or directors; plan administered by independent directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.